Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Marker Therapeutics (MRKR) Interest & Investment Income (2018 - 2025)

Marker Therapeutics (MRKR) has disclosed Interest & Investment Income for 8 consecutive years, with $165628.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income rose 124.59% to $165628.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $594206.0 through Dec 2025, up 35.97% year-over-year, with the annual reading at $594206.0 for FY2025, 35.97% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $165628.0 at Marker Therapeutics, up from $138064.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $218085.0 in Q3 2023, with the low at $791.0 in Q3 2021.
  • Average Interest & Investment Income over 5 years is $91206.8, with a median of $95715.5 recorded in 2022.
  • The sharpest move saw Interest & Investment Income tumbled 98.79% in 2021, then skyrocketed 12510.62% in 2022.
  • Over 5 years, Interest & Investment Income stood at $969.0 in 2021, then surged by 11191.02% to $109410.0 in 2022, then skyrocketed by 84.02% to $201339.0 in 2023, then crashed by 63.37% to $73746.0 in 2024, then soared by 124.59% to $165628.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $165628.0, $138064.0, and $128025.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.